Le Lézard
Classified in: Covid-19 virus
Subjects: Event, Webcast

Skin of Color Society, NEJM Group and VisualDx Launch Free Webinar Series on Addressing Racism in Medicine


Skin of Color Society, NEJM Group, and VisualDx are proud to announce a series of virtual panel discussions that call attention to health disparities and structural racism in medicine. The four-part webinar series, "The Impact of Skin Color and Ethnicity on Clinical Diagnosis and Research," will delve into longstanding problems in education, research, and patient care as well as introduce ways to improve outcomes in marginalized patients.

Studies have shown patients with darker skin experience worse health outcomes than patients with lighter skin. This free series will address the socioeconomic factors, structural racism, and implicit bias that lead to disparities, as well as look at how the medical community can address these issues by offering tangible, real-world solutions. Each discussion will feature insights from renowned experts, thought leaders and advocates that are driving the industry forward to improve the health and lives of underrepresented populations.

The four-part series will feature the following topics and leading physicians:

"For 20 years, we have been committed to improving diagnosis and care in patients with skin of color," said Art Papier, MD, CEO of VisualDx. "We are thrilled to team up with such exemplary partners who share in that commitment. Now is the time to not only talk about racial disparities, but to do something impactful about the problem by equipping our clinicians with the ongoing education, training, and comprehensive information tools needed to improve patient care."

"Implicit bias and structural racism play a central role in the development of health care disparities. One example is misdiagnosis of skin diseases in patients of color," said Kathy Charlton, Managing Director of NEJM Group Education and Applied Knowledge. "NEJM Group is pleased to be a part of this collaborative effort with Skin of Color Society and VisualDx to engage and educate clinicians to strive for diagnostic quality and accuracy in patients of color."

"Founded 16 years ago, the Skin of Color Society's (SOCS) programs in education, research, and mentoring and SOCS' collaboration with other dermatology societies have significantly increased the numbers of underrepresented minority dermatologists, research grants, publications, and educational opportunities in skin of color dermatology. SOCS welcomes this collaboration with NEJM Group and VisualDx. These webinars exemplify the type of education needed to understand implicit bias and eliminate health disparities in people of color," said Lynn McKinley-Grant, MD, FAAD, SOCS President.

These events are free and open to the public but are geared toward frontline healthcare workers. Skin of Color Society, NEJM Group and VisualDx would like to thank Zoom Video Communications for its in-kind support of this webinar series.

For more information on the webinars and expert panelists, and to register, visit https://specialevents.nejm.org/impact-of-skin-color-and-ethnicity-on-clinical-diagnosis-and-research/.

About VisualDx

VisualDx is a company dedicated to improving medical decisions through augmented thinking and timely visualization. It is committed to reducing disparities in medicine and believes technology can bridge gaps in knowledge to bring about more equitable care. The professional product, VisualDx, is the award-winning diagnostic clinical decision support system that has become the standard professional resource at more than 2,300 hospitals worldwide and over half the U.S. medical schools. VisualDx, along with its consumer tool Aysa, combines problem oriented clinical search with the world's best curated medical image library, plus medical knowledge from experts and sophisticated machine learning algorithms to help with differential diagnosis, variation, treatment, and patient communication. Learn more at www.visualdx.com.

About NEJM Group

NEJM Group creates high-quality medical resources for research, learning, practice and professional development designed to meet the demand for essential medical knowledge among academic researchers and teachers, physicians, clinicians, executives and others in medicine and health care. NEJM Group products include the New England Journal of Medicine, NEJM Journal Watch, NEJM Knowledge+, and NEJM Catalyst, NEJM Resident 360, and NEJM Yi Xue Qian Yan. NEJM Group is a division of the Massachusetts Medical Society. For more information visit www.nejmgroup.org.

About Skin of Color Society Foundation

The Skin of Color Society (SOCS) is a professional dermatologic organization dedicated to promoting awareness of, and excellence in, the specialty of skin of color dermatology. The Society was established in 2004 by Susan C. Taylor, MD, and has grown to include members from numerous countries around the world. The Society is committed to wide-ranging educational and investigational pursuits designed to positively impact individuals with skin of color and to ensure the success of dermatologists in serving these individuals through research support, training and mentorship. Learn more at www.skinofcolorsociety.org.


These press releases may also interest you

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

24 avr 2024
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

24 avr 2024
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

24 avr 2024
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...



News published on and distributed by: